⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 26, 2018British Journal of Clinical PharmacologyOpen Access

Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects

Roberto Carnevale Romano Silvestri Lorenzo Loffredo Marta Novo Vittoria Cammisotto Valentina Castellani Simona Bartimoccia Cristina Nocella Francesco Violi

View Full Paper

Ask AI

Bookmark

Share

Abstract

These findings indicate that oleuropein improves postprandial glycaemic profile via hampering Nox2-derived oxidative stress.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Carnevale et al. (2018) studied this question.

synapsesocial.com/papers/69d80a4145af6083e6ae2aaa https://doi.org/10.1111/bcp.13589

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prevention of Diabetes With Mediterranean DietsRCT · 2014 · 650 citations
2State of the Art on Functional Virgin Olive Oils Enriched with Bioactive Compounds and Their PropertiesReview · 2017 · 106 citations
3The Mediterranean diet: health, science and societyOriginal Research · 2015 · 78 citations
4Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trialCohort Study · 2014 · 291 citations
5Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjectsOriginal Research · 2015 · 112 citations

More related papers

Extra-Virgin Olive Oil Reduces Glycemic Response to a High–Glycemic Index Meal in Patients With Type 1 Diabetes: A Randomized Controlled Trial2016
Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study2006
Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health2008

More from British Journal of Clinical Pharmacology

Population pharmacokinetics of levetiracetam in term neonates with hypoxic–ischemic encephalopathy and therapeutic hypothermia: The LEVNEONAT‐1 studyTue,
Pharmacokinetic and pharmacodynamic interaction of enavogliflozin, a sodium‐glucose cotransporter 2 inhibitor, with glimepiride and metformin in healthy participantsTue,